Brief: CytomX Therapeutics Reports Q3 2022 Results
08/11/2022 22:43
Nov 8 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* QTRLY TOTAL REVENUE WAS $16.9 MILLION COMPARED TO $17.6
MILLION
FOR CORRESPONDING PERIOD IN 2021
* QTRLY NET LOSS PER SHARE $0.35
* Q3 EARNINGS PER SHARE VIEW $-0.31, REVENUE VIEW $18.2
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9tq92S
Further company coverage: CTMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway